دورية أكاديمية
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study
| العنوان: | Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study |
|---|---|
| المؤلفون: | Joris, S., Denys, H., Collignon, J., Rasschaert, M., T’Kint de Roodenbeke, D., Duhoux, F.P., Canon, J.-L., Tejpar, S., Mebis, J., Decoster, L., Aftimos, P., De Grève, J. |
| المصدر: | In ESMO Open December 2023 8(6) |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 20597029 |
|---|---|
| DOI: | 10.1016/j.esmoop.2023.102041 |